戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  potential therapeutic targets for high-risk embryonal rhabdomyosarcoma.
2 subgroups of patients with intermediate-risk embryonal rhabdomyosarcoma.
3 rom the two major subtypes, ie, alveolar and embryonal rhabdomyosarcoma.
4 on-arrested and proliferative phenotypes for embryonal rhabdomyosarcoma.
5 ressed at least threefold more myogenin than embryonal rhabdomyosarcomas.
6 unct for distinguishing between alveolar and embryonal rhabdomyosarcomas.
7                            In contrast, most embryonal rhabdomyosarcomas (13 of 15) were either negat
8 in tumors, relapsed high-risk neuroblastoma, embryonal rhabdomyosarcoma, acute myeloid leukemia, and
9 a secondary tumour (head and neck anaplastic embryonal rhabdomyosarcoma), all patients were alive at
10  activity as single agents in both zebrafish embryonal rhabdomyosarcoma and a human cell line of rhab
11           Although the primary cancer was an embryonal rhabdomyosarcoma and there was a family histor
12 atous testicular germ-cell tumors, in 2 of 5 embryonal rhabdomyosarcomas, and in 1 of 266 epithelial
13                                Patients with embryonal rhabdomyosarcoma are generally cured, although
14 nt of lineage (alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma), are particularly sensitive
15 le node-positive or unresectable (group III) embryonal rhabdomyosarcoma arising at certain favorable
16                         The childhood cancer embryonal rhabdomyosarcoma can arise in tissue without s
17 chanisms that prevent MyoD activity in human embryonal rhabdomyosarcoma cells.
18   Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostat
19  partitioning of tumour-propagating cells in embryonal rhabdomyosarcoma, emergence of clonal dominanc
20                                              Embryonal rhabdomyosarcoma (ERMS) and alveolar rhabdomyo
21            Wnt signaling is downregulated in embryonal rhabdomyosarcoma (ERMS) and contributes to the
22                                              Embryonal Rhabdomyosarcoma (ERMS) and Undifferentiated P
23  child was diagnosed with ganglioneuroma and embryonal rhabdomyosarcoma (ERMS) at 2 years of age.
24 y resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-fre
25                                              Embryonal rhabdomyosarcoma (ERMS) is a childhood cancer
26                                              Embryonal rhabdomyosarcoma (ERMS) is a common pediatric
27                                              Embryonal rhabdomyosarcoma (ERMS) is a devastating cance
28                                              Embryonal rhabdomyosarcoma (ERMS) is an aggressive pedia
29                                 A subsequent embryonal rhabdomyosarcoma (eRMS) prognostic model was a
30 fusion protein PAX3-FOXO1 or PAX7-FOXO1, and embryonal rhabdomyosarcoma (ERMS), which is genetically
31 port that YAP1 activity is elevated in human embryonal rhabdomyosarcoma (ERMS).
32 quently shows activation of RAS signaling is embryonal rhabdomyosarcoma (ERMS).
33 omorphic rhabdomyosarcoma (PRMS) compared to embryonal rhabdomyosarcoma (ERMS).
34 n (VA) for patients with subset-one low-risk embryonal rhabdomyosarcoma (ERMS; stage 1/2 group I/II E
35  associated with intermediate- and high-risk embryonal rhabdomyosarcomas (ERMS).
36              Only patients with unresectable embryonal rhabdomyosarcoma (group III) at unfavorable si
37 e a cell of origin for Sonic Hedgehog-driven embryonal rhabdomyosarcoma in an adipocyte-restricted co
38 tiation block in the childhood muscle cancer embryonal rhabdomyosarcoma is often thought to hold prom
39    Assay of PAX3 and PAX7 mRNA expression in embryonal rhabdomyosarcoma, neuroblastoma, Ewing's sarco
40 se with non-metastatic incompletely resected embryonal rhabdomyosarcoma occurring at unfavourable sit
41 n IRS-IV for patients with intermediate-risk embryonal rhabdomyosarcoma (P =.02).
42                              We propose that embryonal rhabdomyosarcomas result from an early block i
43 he spontaneous development of muscle-derived embryonal rhabdomyosarcoma (RMS) after 1 year of age.
44 ntreated patients with incompletely resected embryonal rhabdomyosarcoma (RMS), undifferentiated sarco
45 5 KIP2 gene in normal human tissues, WTs and embryonal rhabdomyosarcoma (RMS).
46                  In contrast, 10 of 11 (91%) embryonal rhabdomyosarcomas showed a methylation pattern
47                                   One of two embryonal rhabdomyosarcomas that strongly stained for my
48 vival rate (FFSR) was 73%, and patients with embryonal rhabdomyosarcoma treated on IRS-IV fared espec
49                               A diagnosis of embryonal rhabdomyosarcoma was made.
50               A KRAS(G12D)-induced zebrafish embryonal rhabdomyosarcoma was then used to assess the t
51 ic variegated aneuploidy, including two with embryonal rhabdomyosarcoma, we identified truncating and
52 rt study identified a group of patients with embryonal rhabdomyosarcoma who had a particularly poor o